ADG126 Clinical Trials

4 actively recruiting trials across 3 locations

Pipeline

Phase 2: 1Phase 1/2: 3

Top Sponsors

Sanofi1
National University Hospital, Singapore1
Hoffmann-La Roche1
Adagene Inc1

Indications

Cancer4
Advanced Liver Cancers1
Advanced/Metastatic Solid Tumors1
Locally Advanced Colorectal Cancer1
Solid Tumor1

Other1 trial

Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer

Phase 2

Scottsdale, Arizona1 trial

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Honor Health Research Institute

Phase 1/2

Costa Mesa, California1 trial

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

UC Irvine Medical Center

Phase 1/2

Newark, Delaware1 trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Christiana Care Health System- Site Number : 8400011

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.